Blogroll
HIV/AIDS networks
Links
- bilaterals.org
- Fix the Patent Laws!
- FTA Malaysia
- HAI Europe
- Health Action International (HAI)
- Intellectual Property Watch
- Lawyers Collective HIV/AIDS
- MSF Access Campaign
- Patent Opposition Database
- Public Citizen
- Stop EU-India FTA
- Stop Peru FTA
- Third World Network
- Treatment Action Group
- UAEM Europe
- UAEM evidence collection
- Universities Allied for Essential Medicines (UAEM)
Archives
-
Recent Posts
- Trump’s Executive Order on Drug Prices Might Be More in Favour of Drug Companies
- The Government Created This Zika Vaccine. Why Should Big Pharma Reap the Profits?
- In Thailand, patient activism is crucial to expanding treatment
- The Trump Executive Order on drug prices: not what was promised nor needed, and contrary to US self interest
- June 2017 Alert: Pressure on countries hiked by US on IP
Categories
Category Archives: Regions
BRICS roots for affordable medicines
Public health targets should be placed above trade deals, says J.P. Nadda By Vidya Krishnan, The Hindu | December 17, 2016 Union Health Minister J.P. Nadda has pressed for public health targets to be placed above trade deals. “Trade regimes … Continue reading
Posted in BRICS, TRIPS plus, Uncategorized
Leave a comment
Open Letter to Ambassadors (in India) of RCEP negotiating countries by Delhi Network of Positive People
Open Letter to Ambassadors of RCEP negotiating countries Member countries Must Consider the Impact of RCEP on Access to Medicines in Developing Countries Don’t trade our lives away! We are writing to you on behalf of the Delhi Network of … Continue reading
GSK expands graduated approach to patents and intellectual property to widen access to medicines in the world’s poorest countries
Source: GSK Press Release, 31 March 2016 Adopts approach to intellectual property reflecting a country’s economic maturity Will not file for patent protection in Least Developed and Low Income Countries Will seek to grant licences to generic manufacturers to supply … Continue reading
Posted in IP Rights, LDCs, Medicine Patent Pool, Patent, Uncategorized
Leave a comment
Curing Hepatitis C, in an Experiment the Size of Egypt
The New York Times; December 16, 2015. SHABAS EL SHUHADA, Egypt — Abdel Gawad Ellabbad knows exactly how he was infected with hepatitis C. As a schoolboy in this Nile Delta rice-farming village, his class marched to the local clinic every month … Continue reading
Posted in Africa, Hepatitis C, Pricing, Sofosbuvir
Leave a comment
Speak up for affordable medicine
Iol news, Nobember 19, 2015. US and European pharmaceutical industries see South Africa as “ground zero” for keeping their large profit margins, say Julia Hill and Catherine Tomlinson.
Tackling Antimicrobial Resistance Is an Area BRIC Countries Can Lead the World – They Must Take This Opportunity
Huffington Post; November 12, 2015. Brazil, India, Russia and China have gone through a period of rapid economic development, making them important global players in the 21st century. However, they are also the countries that might be affected most severely by growing antimicrobial … Continue reading
Posted in Antibiotics, BRICS, Innovation
Leave a comment
US Chamber of Commerce lauds USPTO for securing a time-bound LDC waiver for pharmaceutical products
Knowledge Ecology International; November 12, 2015. Nestled at the end Intellectual Property Watch’s (IP-Watch) brilliant reportage of a US Chamber of Commerce event – “Has the Sun Set on Multilateral Rulemaking on IP?” – is a quote by Patrick Kilbride (Executive … Continue reading
Posted in LDC transition period
Leave a comment
